These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14722349)

  • 1. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.
    Riley P; Maillard SM; Wedderburn LR; Woo P; Murray KJ; Pilkington CA
    Rheumatology (Oxford); 2004 Apr; 43(4):491-6. PubMed ID: 14722349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
    Al-Mayouf SM; Laxer RM; Schneider R; Silverman ED; Feldman BM
    J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.
    Riley P; McCann LJ; Maillard SM; Woo P; Murray KJ; Pilkington CA
    Rheumatology (Oxford); 2008 Jun; 47(6):877-80. PubMed ID: 18403404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous cyclophosphamide pulse therapy for refractory juvenile dermatomyositis].
    Nakashima S; Mori M; Miyamae T; Ito S; Ibe M; Aihara Y; Yokota S
    Ryumachi; 2002 Dec; 42(6):895-902. PubMed ID: 12632609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.
    Qushmaq KA; Chalmers A; Esdaile JM
    J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
    Illei GG; Yarboro CH; Kuroiwa T; Schlimgen R; Austin HA; Tisdale JF; Chitkara P; Fleisher T; Klippel JH; Balow JE; Boumpas DT
    Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of intravenous megadoses of methylprednisolone for treatment of dermatomyositis in children].
    Romicka AM
    Pediatr Pol; 1995 Mar; 70(3):243-8. PubMed ID: 8657493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry.
    Bader-Meunier B; Decaluwe H; Barnerias C; Gherardi R; Quartier P; Faye A; Guigonis V; Pagnier A; Brochard K; Sibilia J; Gottenberg JE; Bodemer C;
    J Rheumatol; 2011 Jul; 38(7):1436-40. PubMed ID: 21677003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
    Deakin CT; Campanilho-Marques R; Simou S; Moraitis E; Wedderburn LR; Pullenayegum E; Pilkington CA;
    Arthritis Rheumatol; 2018 May; 70(5):785-793. PubMed ID: 29342499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis.
    De Feo LG; Schottlender J; Martelli NA; Molfino NA
    Muscle Nerve; 2002 Jul; 26(1):31-6. PubMed ID: 12115946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
    J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey.
    Stringer E; Bohnsack J; Bowyer SL; Griffin TA; Huber AM; Lang B; Lindsley CB; Ota S; Pilkington C; Reed AM; Scuccimarri R; Feldman BM
    J Rheumatol; 2010 Sep; 37(9):1953-61. PubMed ID: 20595275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
    Lovell DJ; Lindsley CB; Rennebohm RM; Ballinger SH; Bowyer SL; Giannini EH; Hicks JE; Levinson JE; Mier R; Pachman LM; Passo MH; Perez MD; Reed AM; Schikler KN; Smith M; Zemel LS; Rider LG
    Arthritis Rheum; 1999 Oct; 42(10):2213-9. PubMed ID: 10524696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
    Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
    Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
    Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
    J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
    Marks SD; Patey S; Brogan PA; Hasson N; Pilkington C; Woo P; Tullus K
    Arthritis Rheum; 2005 Oct; 52(10):3168-74. PubMed ID: 16200620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
    McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
    Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases.
    Zeller V; Cohen P; Prieur AM; Guillevin L
    J Rheumatol; 1996 Aug; 23(8):1424-7. PubMed ID: 8856623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of juvenile dermatomyositis.
    Stringer E; Feldman BM
    Curr Opin Rheumatol; 2006 Sep; 18(5):503-6. PubMed ID: 16896290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.